The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsLoading episode
Fetching episode details...
Radio and PodcastLive Radio & PodcastsRadio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsFDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small cell lung cancer. Released July 25, 2017
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer is an episode from FDA Drug Information Updates by ReachMD. FDA medical oncologists discuss the FDA approvals of brigatinib and ceritinib for ALK-positive non-small c...
This episode belongs to FDA Drug Information Updates.
Use the player on this page to stream the episode online.
Published Jul 25, 2017, 00:09:00 long, audio available.
Continue listening to more episodes from FDA Drug Information Updates.
Jul 31, 2018 - 00:24:45
May 4, 2018 - 00:02:59
Jan 7, 2018 - 00:08:29
Jan 5, 2018 - 00:02:59
Oct 29, 2017 - 00:09:22
Aug 17, 2017 - 00:05:29
Jul 28, 2017 - 00:06:00